Publications by authors named "Myoung-Rin Park"
. Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC.
View Article and Find Full Text PDFArticle Synopsis
- Small cell lung cancer (SCLC) is an aggressive cancer with low survival rates, and this study aimed to identify factors related to long-term survival (beyond 2 years) in patients.
- Out of 242 patients diagnosed with SCLC, only 25.2% (61 patients) survived longer than 2 years; key factors influencing survival included CRP levels, TNM staging, and progression-free survival (PFS).
- The study highlights the importance of PFS in managing SCLC patients, suggesting that monitoring these prognostic factors can aid in understanding patient outcomes better.
Atypical adenomatous hyperplasia (AAH) has been considered to be a precursor lesion of bronchioloalveolar carcinoma (BAC) and pulmonary adenocarcinoma. It usually coexists with BAC and/or an adenocarcinoma. Chest computed tomography reveals multiple well-defined nodules with ground-glass opacity.
View Article and Find Full Text PDFArticle Synopsis
- Non-small cell lung cancer (NSCLC) is the most common cause of cancer deaths, often diagnosed at an advanced stage.
- Complete remission (CR) is difficult to achieve solely with traditional chemotherapy or targeted therapies.
- Two patients with advanced NSCLC who initially achieved CR with chemotherapy experienced a recurrence, but after retreatment with the same regimens, they again reached CR and have maintained this status.